Troglitazone, a Peroxisome Proliferator-activated Receptor γ (PPARγ) Ligand, Selectively Induces the Early Growth Response-1 Gene Independently of PPARγ

This publication has 53 references indexed in Scilit:

• Troglitazone Inhibits Growth of MCF-7 Breast Carcinoma Cells by Targeting G1 Cell Cycle Regulators
  Biochemical and Biophysical Research Communications, 2001
• Induction of Egr-1 expression by the retinoid AHPN in human lung carcinoma cells is dependent on activated ERK1/2
  Cell Death & Differentiation, 2001
• Combinations of ERK and p38 MAPK Inhibitors Ablate Tumor Necrosis Factor-α (TNF-α) mRNA Induction
  Journal of Biological Chemistry, 2001
• Effects of Troglitazone on Cellular Differentiation, Insulin Signaling, and Glucose Metabolism in Cultured Human Skeletal Muscle Cells
  Biochemical and Biophysical Research Communications, 2001
• The Transcription Factor EGR-1 Directly Transactivates the Fibronectin Gene and Enhances Attachment of Human Glioblastoma Cell Line U251
  Journal of Biological Chemistry, 2000
• Troglitazone Suppresses Cell Growth of Myeloid Leukemia Cell Lines by Induction of p21WAF1/CIP1 Cyclin-Dependent Kinase Inhibitor
  Biochemical and Biophysical Research Communications, 1999
• Peroxisome Proliferator‐activated Receptor γ Induces Growth Arrest and Differentiation Markers of Human Colon Cancer Cells
  Japanese Journal of Cancer Research, 1999
• PPARγ3 mRNA: a distinct PPARγ mRNA subtype transcribed from an independent promoter
  FEBS Letters, 1998
• Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation
  International Journal of Cancer, 1997
• Inhibition of Adipogenesis Through MAP Kinase-Mediated Phosphorylation of PPARγ
  Science, 1996